This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human S100A9 DuoSet ELISA
catalog :
DY5578
quantity :
1 Kit (for 15 Plates)
price :
850 USD
citations: 9
Reference
Li X, Li Q, Xiang X, Zhang X, Wu Y. The diagnostic value and clinical correlations of bone marrow supernatant S100A8 and S100A9 in myelodysplastic neoplasms. Cytokine. 2025;187:156856 pubmed publisher
Henrioux F, Navel V, Belville C, Charnay C, Antoine A, Chiambaretta F, et al. Inflammation of Dry Eye Syndrome: A Cellular Study of the Epithelial and Macrophagic Involvement of NFAT5 and RAGE. Int J Mol Sci. 2023;24: pubmed publisher
Daily A, Ravishankar P, Harms S, Klimberg V. Using tears as a non-invasive source for early detection of breast cancer. PLoS ONE. 2022;17:e0267676 pubmed publisher
Monteiro C, Miarka L, Perea García M, Priego N, García Gómez P, Álvaro Espinosa L, et al. Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism. Nat Med. 2022;28:752-765 pubmed publisher
Xiang H, Guo F, Tao X, Zhou Q, Xia S, Deng D, et al. Pancreatic ductal deletion of S100A9 alleviates acute pancreatitis by targeting VNN1-mediated ROS release to inhibit NLRP3 activation. Theranostics. 2021;11:4467-4482 pubmed publisher
Radujkovic A, Boch T, Nolte F, Nowak D, Kunz C, Gieffers A, et al. Clinical Response to the CD95-Ligand Inhibitor Asunercept Is Defined by a Pro-Inflammatory Serum Cytokine Profile. Cancers (Basel). 2020;12: pubmed publisher
Lv Z, Li W, Wei X. S100A9 promotes prostate cancer cell invasion by activating TLR4/NF-κB/integrin β1/FAK signaling. Onco Targets Ther. 2020;13:6443-6452 pubmed publisher
Gouin E, Balestrino D, Raşid O, Nahori M, Villiers V, Impens F, et al. Ubiquitination of Listeria Virulence Factor InlC Contributes to the Host Response to Infection. MBio. 2019;10: pubmed publisher
Lozano E, Diaz T, Mena M, Suñé G, Calvo X, Calderón M, et al. Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma. J Immunol. 2018;200:2581-2591 pubmed publisher
product information
master code :
DY5578
SKU :
DY5578
product name :
Human S100A9 DuoSet ELISA
unit size :
1 Kit (for 15 Plates)
description :
The Human S100A9 DuoSet ELISA from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human S100A9.
target :
S100A9
category :
ELISAs
species :
Human
gene symbol :
S100A9
kit type :
Solid Phase Sandwich ELISA
elisaRange :
31.20 - 2000 pg/mL
top caption :
Human S100A9 ELISA Standard Curve
applications :
ELISA
USD :
850 USD
alt names :
CAGBMigration inhibitory factor-related protein 14, calgranulin B, calgranulin-B, Calprotectin L1H subunit, CFAGMRP-14,60B8AG, CGLB, L1AG, LIAG, MAC387, MIF, MRP-14, MRP14Leukocyte L1 complex heavy chain, NIF, P14, protein S100-A9, S100 calcium binding protein A9, S100 calcium binding protein A9 (calgranulin B), S100 calcium-binding protein A9, S100 calcium-binding protein A9 (calgranulin B)
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.